Contact US
Approaching the end of an era for animal testing

Blogs

Approaching the end of an era for animal testing

The existing drug development paradigm was established in 1938 under the Federal Food, Drug, and Cosmetics Act (FFDCA) and still...

Read More

PREDiCT Tumor Models London 2022

Meet Us

PREDiCT Tumor Models London 2022

Imagen proudly partners with the 11th Annual PREDiCT Tumor Models London, to deliver the latest insights into cutting edge preclinical...

Read More

Antibody-drug conjugate (ADC) cytotoxicity assay

Product Sheets

Antibody-drug conjugate (ADC) cytotoxicity assay

Test the efficacy of your ADC using clinically relevant patient-derived cell (PDC) models

Read More

Three main challenges in lung cancer treatment

Blogs

Three main challenges in lung cancer treatment

Despite the improvement in clinical outcomes derived by the introduction of innovative targeted therapies and immunotherapies, lung cancer remains a...

Read More

Next generation patient-derived ex vivo models drive functional precision medicine

Blogs

Next generation patient-derived ex vivo models drive functional precision medicine

Typical ex vivo chemosensitivity assays initially designed to expose patient-derived cancer cells to certain drugs seemed an obvious and compelling...

Read More

What is Precision Medicine?

Blogs

What is Precision Medicine?

Traditional oncology treatments were designed to rapidly kill fast proliferating cells in a one-size-fits-all. However, once the first draft of...

Read More

predictTx Screen

Product Sheets

predictTx Screen

A pan-solid tumor drug screening service to help you move your drug development pipeline with confidence to the clinic

Read More

HER2 positive

Model Spotlight

HER2 positive

Amplification or overexpression of HER2 occurs in approximately 15–30% of breast cancers and 10–30% of gastric/gastroesophageal cancers and serves as...

Read More

EGFR mutant, EGFRi resistant NSCLC

Model Spotlight

EGFR mutant, EGFRi resistant NSCLC

Amplification or overexpression of HER2 occurs in approximately 15–30% of breast cancers and 10–30% of gastric/gastroesophageal cancers and serves as...

Read More

Why prefer Patient-Derived Cell (PDC) models to cancer cell lines for drug development

Blogs

Why prefer Patient-Derived Cell (PDC) models to cancer cell lines for drug development

For more than 25 years, the NCI-60, a panel of 60 human cancer cell lines grown in vitro, has been...

Read More

PredictDb

Product Sheets

PredictDb

Access the largest collection of Patient-Derived Cell (PDC) model data anytime and from anywhere

Read More

AACR 2022

Posters

AACR 2022

Discover our research presented at the 2022 AACR annual meeting

Read More

predictRx

Product Sheets

predictRx

predictRx is Imagen’s pioneering in vitro diagnostic platform that helps oncologists find the right treatment for each unique cancer patient...

Read More

predictTx

Product Sheets

predictTx

predictTx is Imagen’s suite of in vitro pharmacology services that harness the power of 100’s of clinically relevant 2D and...

Read More

Imagen Services Portfolio

Product Sheets

Imagen Services Portfolio

Discover the power of our Patient-derived cell (PDC) model and high content imaging platform. Lengthy and costly drug development programs...

Read More

Can PDC models improve oncology drug attrition rates?

Blogs

Can PDC models improve oncology drug attrition rates?

A large and well characterised biobank of patient-derived cell models can significantly accelerate drug development timelines and fast track decisions...

Read More

When and how to use PDC in drug development

Blogs

When and how to use PDC in drug development

So, you’ve used conventional methodologies to identify a target, designed a series of candidate drugs and validated a biomarker for...

Read More

Patient-Derived Cell (PDC) Models as a Tool to Assess Cancer Therapeutic Efficacy Across the Drug Development Life Cycle

Posters

Patient-Derived Cell (PDC) Models as a Tool to Assess Cancer Therapeutic Efficacy Across the Drug Development Life Cycle

Patient-derived cell (PDC) models bridge the gap between conventional cancer lines that do not faithfully replicate clinical responses and costly...

Read More

Differential sensitivity to poly (ADP-ribose) polymerase inhibitors in patient-derived cell models of breast cancer

Posters

Differential sensitivity to poly (ADP-ribose) polymerase inhibitors in patient-derived cell models of breast cancer

New treatment strategies are urgently needed for metastatic breast cancer, which remains an area of high unmet need with poor...

Read More

Next generation in vitro models for oncology R&D – relevance is key

Blogs

Next generation in vitro models for oncology R&D – relevance is key

So, you’ve used conventional methodologies to identify a target, designed a series of candidate drugs and validated a biomarker for...

Read More

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Youtube
Consent to display content from Youtube
Vimeo
Consent to display content from Vimeo
Google Maps
Consent to display content from Google
Spotify
Consent to display content from Spotify
Sound Cloud
Consent to display content from Sound
Contact Us

© Copyright 2022 Imagen Therapeutics Ltd